P. Holma

发表

Cholesterol and HDL-cholesterol values in women during use of subdermal implants releasing levonorgestrel.

P. Holma, D. Robertson, 1985, Contraception.

Serum lipids and proteins during treatment with a new oral contraceptive combination containing desogestrel.

I. Penttilä, M. Makkonen, O. Castrén, 1983, European journal of obstetrics, gynecology, and reproductive biology.

Norplant consensus statement and background review.

I. Fraser, D. Mishell, B. V. VON Schoultz, 1998, Contraception.

Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.

N. Nielsen, L. Lampé, M. Osler, 1987, Contraception.

Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding.

T. Pyörälä, P. Holma, E. W. Bergink, 1981, Scandinavian journal of clinical and laboratory investigation.

Effects of an anabolic steroid (metandienone) on spermatogenesis.

P. Holma, 1977, Contraception.

EFFECTS OF m ANABOLIC STEROID (METANDIENOKE) ON SPEPMATO- GENESIS

P. Holma, 1977 .

Effect of an anabolic steroid (metandienon) on plasma LH-FSH, and testosterone and on the response to intravenous administration of LRH.

H. Adlercreutz, P. Holma, 1976, Acta endocrinologica.

Long-term experience with Norplant contraceptive implants in Finland.

P. Holma, 1985, Contraception.

Vaginal progesterone after tubal pregnancy.

J. Mäkinen, M. Hippeläinen, M. Pulkkinen, 1993, European journal of obstetrics, gynecology, and reproductive biology.

The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.

I. Sivin, L. Wan, A. Biswas, 1998, Human reproduction.

Clinical performance of a new two-rod levonorgestrel contraceptive implant: a three-year randomized study with Norplant implants as controls.

I. Sivin, L. Wan, S. Díaz, 1997, Contraception.

Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.

D. Mishell, I. Sivin, P. Darney, 1992, American journal of obstetrics and gynecology.

Three-year experience with NORPLANT subdermal contraception.

I. Sivin, E. Coutinho, S. Díaz, 1983, Fertility and sterility.

A four-year clinical study of NORPLANT implants.

I. Sivin, S. Díaz, P. Holma, 1983, Studies in family planning.

Menstrual blood loss with contraceptive subdermal levonorgestrel implants.

C. Nilsson, P. Holma, 1981, Fertility and sterility.

Long-term contraception with norethindrone subcutaneous capsules.

E. Vartiainen, T. Luukkainen, E. Johansson, 1976, Annals of clinical research.

Prolonged effectiveness of Norplant(R) capsule implants: a 7-year study.

D. Mishell, I. Sivin, P. Darney, 2000, Contraception.

Long-term experience with Norplant implants in international clinical trials.

I. Sivin, S. Díaz, P. Holma, 1984, Contraceptive delivery systems.

The NORPLANT contraceptive method: a report on three years of use.

I. Sivin, E. Coutinho, S. Díaz, 1982, Studies in family planning.

Norplant: reversible implant contraception.

N. Nielsen, I. Sivin, E. Coutinho, 1980, Studies in family planning.

Contraception with long-acting subdermal implants. A five-year clinical trial with Silastic covered rod implants containing levonorgestrel. The International Committee for Contraception Research (ICCR) of the Population Council.

D. Mishell, E. Coutinho, H. Croxatto, 1985, Contraception.

LONG-TERM EXPERIENCE WITH NORPLANTR CONTRACEPTIVE IMPLANTS

P. Holma, 1985 .

Transdermal oestrogen replacement therapy in a Finnish population.

S. Nummi, T. Raudaskoski, R. Erkkola, 1991, Maturitas.